首页 » OCI-LY8 BioVector®人弥漫大B细胞淋巴瘤细胞系 / Human Diffuse Large B-cell Lymphoma Cell Line BioVector® NTCC典型培养物保藏中心

OCI-LY8 BioVector®人弥漫大B细胞淋巴瘤细胞系 / Human Diffuse Large B-cell Lymphoma Cell Line BioVector® NTCC典型培养物保藏中心

  • 价  格:¥99850
  • 货  号:BioVector® OCI-LY8
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作微信:1843439339 (QQ同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

BioVector® OCI-LY8 人弥漫大B细胞淋巴瘤细胞系 / Human Diffuse Large B-cell Lymphoma Cell Line 数据说明书

产品名称: BioVector® OCI-LY8 细胞
同义词: BioVector® OCI-Ly8; BioVector® OCILY8; BioVector® OCI-LY08; BioVector® LY8
中文名称: BioVector® OCI-LY8 人弥漫性大B细胞淋巴瘤细胞系
英文名称: BioVector® OCI-LY8 Human Diffuse Large B-cell Lymphoma Cell Line
产品类别: 血液肿瘤细胞系
物种来源: 人 (Homo sapiens)
组织来源: 外周血
疾病: 弥漫性大B细胞淋巴瘤(DLBCL);免疫母细胞性B细胞淋巴瘤
患者信息: 未知
构建时间: 1990年左右建立
形态特性: 悬浮生长,呈圆形或椭圆形,以中心母细胞形态为主

OCI-LY8 Cell Line|人弥漫大B淋巴瘤细胞价格厂家:上海弘顺生物科技有限公司

生长特性: 悬浮生长

构建方法: 从弥漫性大B细胞淋巴瘤患者的外周血样本中建立
特性特征:

  1. EB病毒状态: EBV阴性

  2. 分子亚类: 根据基因表达谱分析,属于活化B细胞样(ABC)亚型

  3. “双重打击”淋巴瘤: 被归类为“双重打击”淋巴瘤衍生的细胞系

  4. 染色体易位: 携带染色体8p23.1易位,涉及MASL1癌基因;该易位产生MASL1外显子1与14q21区域隐性外显子的嵌合转录本

  5. 基因突变: TP53基因突变

  6. 免疫表型: CD20+, CD10+, CD3-;Bcl-6阴性,MUM-1阴性

  7. FTO表达: FTO(脂肪量和肥胖相关蛋白)表达水平较高,与利妥昔单抗耐药相关

  8. 研究应用: 弥漫性大B细胞淋巴瘤(DLBCL)的生物学特性研究、药物筛选(特别是利妥昔单抗耐药机制研究)、治疗策略开发的重要体外模型
    培养基: BioVector® OCI-LY8 细胞专用完全培养基(推荐基础成分:RPMI-1640培养基,添加10%胎牛血清和1%青霉素-链霉素) -3-4
    培养条件: 气相:95%空气,5%二氧化碳;温度:37°C -3-4
    传代方法: 维持细胞密度在2×10⁵ - 1×10⁶ cells/mL之间,每2-3天传代或更换新鲜培养基
    冻存液: BioVector® 细胞冻存液(推荐配方:90%胎牛血清 + 10% DMSO)
    质控载体: BioVector® pUC19 质粒
    宿主菌: BioVector® DH5α 化学感受态细胞
    质量控制: 支原体检测:阴性;无菌检测:阴性;STR分型:已验证

  9. IRF8 is a transcriptional activator of CD37 expression in diffuse large B- cell lymphoma - ScienceDirect

  10. STR分型数据:
    Amelogenin: X
    CSF1PO: 10,12
    D13S317: 11
    D16S539: 11,12
    D5S818: 11,12
    D7S820: 9,10
    TH01: 8,9
    TPOX: 8,11
    vWA: 14,18
    储存与运输: 液氮或干冰运输与保存(-150°C至-190°C)
    生物安全等级: 1(需在二级生物安全柜内操作)
    仅供科研使用


English:
BioVector® OCI-LY8 Human Diffuse Large B-cell Lymphoma Cell Line Datasheet

Product Name: BioVector® OCI-LY8 Cells
Synonyms: BioVector® OCI-Ly8; BioVector® OCILY8; BioVector® OCI-LY08; BioVector® LY8
Chinese Name: BioVector® OCI-LY8 人弥漫性大B细胞淋巴瘤细胞系
English Name: BioVector® OCI-LY8 Human Diffuse Large B-cell Lymphoma Cell Line
Product Category: Hematologic Cancer Cell Line
Species of Origin: Human (Homo sapiens)
Tissue of Origin: Peripheral blood
Disease: Diffuse Large B-cell Lymphoma (DLBCL); Immunoblastic B-cell Lymphoma
Patient Information: Unknown
Year Established: Approximately 1990
Morphology: Suspension growth, round to oval cells, predominantly centroblastic morphology -2
Growth Characteristics: Suspension
Derivation: Established from peripheral blood sample of a patient with Diffuse Large B-cell Lymphoma
Characteristics:

  1. EBV Status: Negative -5

  2. Molecular Subtype: Classified as Activated B-cell-like (ABC) subtype based on gene expression profiling

  3. "Double Hit" Lymphoma: Categorized as a cell line derived from "double hit" lymphoma -9

  4. Chromosomal Translocation: Carries a translocation at chromosome 8p23.1 involving the MASL1 oncogene; this translocation produces a chimeric transcript of MASL1 exon 1 with a cryptic exon from the 14q21 genomic region -8

  5. Gene Mutation: TP53 gene mutation -7

  6. Immunophenotype: CD20+, CD10+, CD3-; Bcl-6 negative, MUM-1 negative -2

  7. FTO Expression: High expression of FTO (Fat mass and obesity-associated protein), associated with Rituximab resistance -9

  8. Research Applications: Important in vitro model for studying DLBCL biology, drug screening (particularly Rituximab resistance mechanisms), and therapeutic strategy development -9
    Culture Medium: BioVector® Complete Medium for OCI-LY8 Cells (Recommended composition: RPMI-1640 medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin) -3-4
    Culture Conditions: Atmosphere: 95% air, 5% CO₂; Temperature: 37°C -3-4
    Subculturing Method: Maintain cell density between 2×10⁵ - 1×10⁶ cells/mL; subculture or replenish with fresh medium every 2-3 days
    Freeze Medium: BioVector® Cell Freeze Medium (Recommended composition: 90% FBS + 10% DMSO)
    Control Vector: BioVector® pUC19 Plasmid
    Host Strain: BioVector® DH5α Chemically Competent Cells
    Quality Control: Mycoplasma: Negative; Sterility: Negative; STR Profiling: Authenticated
    STR Profile Data:
    Amelogenin: X
    CSF1PO: 10,12
    D13S317: 11
    D16S539: 11,12
    D5S818: 11,12
    D7S820: 9,10
    TH01: 8,9
    TPOX: 8,11
    vWA: 14,18
    Storage and Shipment: Stored and shipped in liquid nitrogen or on dry ice (-150°C to -190°C)
    Biosafety Level: 1 (Operate in a Class II biological safety cabinet)
    For Research Use Only


BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心

电话:400-800-2947

工作QQ/微信同号:1843439339

网址http://www.biovector.net


您正在向 biovector.net  发送关于产品 OCI-LY8 BioVector®人弥漫大B细胞淋巴瘤细胞系 / Human Diffuse Large B-cell Lymphoma Cell Line BioVector® NTCC典型培养物保藏中心 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。